173 related articles for article (PubMed ID: 33139332)
21. The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer.
Turvill JL; Turnock D; Cottingham D; Haritakis M; Jeffery L; Girdwood A; Hearfield T; Mitchell A; Keding A
Br J Gen Pract; 2021 Aug; 71(709):e643-e651. PubMed ID: 33798091
[TBL] [Abstract][Full Text] [Related]
22. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
[TBL] [Abstract][Full Text] [Related]
23. One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China.
Wang L; Chen H; Zhu Y; Lu M; Wang Y; Chen X; Ma W; Du L; Chen W
BMJ Open; 2022 May; 12(5):e059754. PubMed ID: 35589365
[TBL] [Abstract][Full Text] [Related]
24. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the QuikRead go
Maclean W; Zahoor Z; O'Driscoll S; Piggott C; Whyte MB; Rockall T; Jourdan I; Benton SC
Clin Chem Lab Med; 2022 Jan; 60(1):101-108. PubMed ID: 34679264
[TBL] [Abstract][Full Text] [Related]
26. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
[TBL] [Abstract][Full Text] [Related]
27. Sociodemographic variations in the uptake of faecal immunochemical tests in primary care: a retrospective study.
Bailey JA; Morton AJ; Jones J; Chapman CJ; Oliver S; Morling JR; Patel H; Banerjea A; Humes DJ
Br J Gen Pract; 2023 Nov; 73(736):e843-e849. PubMed ID: 37845084
[TBL] [Abstract][Full Text] [Related]
28. Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis.
Pin-Vieito N; Tejido-Sandoval C; de Vicente-Bielza N; Sánchez-Gómez C; Cubiella J
Gut; 2022 May; 71(5):950-960. PubMed ID: 34108236
[TBL] [Abstract][Full Text] [Related]
29. 'Low' faecal immunochemical test (FIT) colorectal cancer: a 4-year comparison of the Nottingham '4F' protocol with FIT10 in symptomatic patients.
Bailey JA; Morton AJ; Jones J; Chapman CJ; Oliver S; Morling JR; Patel H; Humes DJ; Banerjea A
Colorectal Dis; 2024 Feb; 26(2):309-316. PubMed ID: 38173125
[TBL] [Abstract][Full Text] [Related]
30. Faecal immunochemical tests for occult blood testing should not be used outside of bowel screening: an audit of a large general practice.
Byun UH; Anderson N; Upton A; Frankish P
J Prim Health Care; 2019 Sep; 11(3):259-264. PubMed ID: 32171379
[TBL] [Abstract][Full Text] [Related]
31. Faecal immunochemical test outside colorectal cancer screening?
Pin-Vieito N; Puga M; Fernández-de-Castro D; Cubiella J
World J Gastroenterol; 2021 Oct; 27(38):6415-6429. PubMed ID: 34720531
[TBL] [Abstract][Full Text] [Related]
32. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
[TBL] [Abstract][Full Text] [Related]
33. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
D'Souza N; Georgiou Delisle T; Chen M; Benton S; Abulafi M;
Gut; 2021 Jun; 70(6):1130-1138. PubMed ID: 33087488
[TBL] [Abstract][Full Text] [Related]
34. Replicate and repeat faecal immunochemical tests in symptomatic patients: A systematic review.
Farkas NG; Fraser CG; Maclean W; Jourdan I; Rockall T; Benton SC
Ann Clin Biochem; 2023 Jan; 60(1):27-36. PubMed ID: 35394384
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of 13,466 Fecal Immunochemical Tests in Patients Attending Primary Care for High- and Low-Risk Gastrointestinal Symptoms of Colorectal Cancer.
Cama R; Kapoor N; Sawyer P; Patel B; Landy J
Dig Dis Sci; 2023 May; 68(5):2023-2029. PubMed ID: 36357596
[TBL] [Abstract][Full Text] [Related]
36. Combining faecal immunochemical testing with blood test results for colorectal cancer risk stratification: a consecutive cohort of 16,604 patients presenting to primary care.
Withrow DR; Shine B; Oke J; Tamm A; James T; Morris E; Davies J; Harris S; East JE; Nicholson BD
BMC Med; 2022 Mar; 20(1):116. PubMed ID: 35287679
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients.
Maclean W; Mackenzie P; Limb C; Zahoor Z; Whyte MB; Rockall T; Benton SC; Jourdan I
Colorectal Dis; 2021 Sep; 23(9):2376-2386. PubMed ID: 34157205
[TBL] [Abstract][Full Text] [Related]
38. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.
Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ
Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134
[TBL] [Abstract][Full Text] [Related]
39. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.
Fraser CG
Surgeon; 2018 Oct; 16(5):302-308. PubMed ID: 29548552
[TBL] [Abstract][Full Text] [Related]
40. Detection of Chitinase 3-Like 1 in Symptomatic Primary Care Patient Faecal Samples is Not a Reliable Biomarker of Colonic Lesions.
Keenan JI; Aitchison A; Frizelle FA; Hock BD
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2289-2293. PubMed ID: 37505758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
